One of the early mutations discovered was O6-methylguanine-DNA methyltransferase (MGMT) promoter silencing, which reduces tumor cells’ ability to repair DNA damage from alkylating agents such as temozolomide (TMZ). This evidence concerns the gene MGMT and neoplasm.